168 related articles for article (PubMed ID: 35749951)
1. DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas.
Jurmeister P; Leitheiser M; Wolkenstein P; Klauschen F; Capper D; Brcic L
Lung Cancer; 2022 Aug; 170():105-113. PubMed ID: 35749951
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
Wu D; Hiroshima K; Matsumoto S; Nabeshima K; Yusa T; Ozaki D; Fujino M; Yamakawa H; Nakatani Y; Tada Y; Shimada H; Tagawa M
Am J Clin Pathol; 2013 Jan; 139(1):39-46. PubMed ID: 23270897
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics.
Bertero L; Righi L; Collemi G; Koelsche C; Hou Y; Stichel D; Schrimpf D; Flucke U; Petersen I; Vokuhl C; Fröhling S; Bironzo P; Scagliotti GV; Cassoni P; Papotti M; von Deimling A
J Mol Diagn; 2021 Jul; 23(7):834-846. PubMed ID: 33887463
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.
Fujii M; Fujimoto N; Hiraki A; Gemba K; Aoe K; Umemura S; Katayama H; Takigawa N; Kiura K; Tanimoto M; Kishimoto T
Cancer Sci; 2012 Mar; 103(3):510-4. PubMed ID: 22146010
[TBL] [Abstract][Full Text] [Related]
6. Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.
Sato H; Soh J; Aoe K; Fujimoto N; Tanaka S; Namba K; Torigoe H; Shien K; Yamamoto H; Tomida S; Tao H; Okabe K; Kishimoto T; Toyooka S
Int J Oncol; 2019 Jun; 54(6):2139-2148. PubMed ID: 30942424
[TBL] [Abstract][Full Text] [Related]
7. On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).
Barbieri PG
Tumori; 2019 Aug; 105(4):361-362. PubMed ID: 30592233
[No Abstract] [Full Text] [Related]
8. On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).
Pira E; Boffetta P; Ciocan C
Tumori; 2019 Aug; 105(4):359-360. PubMed ID: 31418338
[No Abstract] [Full Text] [Related]
9. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Carbone M; Shimizu D; Napolitano A; Tanji M; Pass HI; Yang H; Pastorino S
Oncotarget; 2016 Sep; 7(37):59314-59321. PubMed ID: 27447750
[TBL] [Abstract][Full Text] [Related]
10. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.
Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S
Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922
[TBL] [Abstract][Full Text] [Related]
11. Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort.
Allione A; Viberti C; Cotellessa I; Catalano C; Casalone E; Cugliari G; Russo A; Guarrera S; Mirabelli D; Sacerdote C; Gentile M; Eichelmann F; Schulze MB; Harlid S; Eriksen AK; Tjønneland A; Andersson M; Dollé MET; Van Puyvelde H; Weiderpass E; Rodriguez-Barranco M; Agudo A; Heath AK; Chirlaque MD; Truong T; Dragic D; Severi G; Sieri S; Sandanger TM; Ardanaz E; Vineis P; Matullo G
Int J Cancer; 2023 Feb; 152(4):725-737. PubMed ID: 36305648
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.
Christensen BC; Marsit CJ; Houseman EA; Godleski JJ; Longacker JL; Zheng S; Yeh RF; Wrensch MR; Wiemels JL; Karagas MR; Bueno R; Sugarbaker DJ; Nelson HH; Wiencke JK; Kelsey KT
Cancer Res; 2009 Aug; 69(15):6315-21. PubMed ID: 19638575
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic role of video-assisted thoracoscopic surgery in exudative pleural effusion and follow-up results in patients with nonspecific pleuritis.
Arkin FS; Kutluk AC; Gorgun D; Cansever L; Kocaturk C; Yildiz P; Bedirhan MA
J Pak Med Assoc; 2019 Aug; 69(8):1103-1107. PubMed ID: 31431761
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
Klebe S; Swalling A; Jonavicius L; Henderson DW
J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
[TBL] [Abstract][Full Text] [Related]
16. SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma.
Nakagiri T; Amatya VJ; Kushitani K; Kambara T; Aoe K; Endo I; Miyata Y; Okada M; Takeshima Y
Am J Surg Pathol; 2024 Feb; 48(2):140-149. PubMed ID: 37899530
[TBL] [Abstract][Full Text] [Related]
17. MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Maille E; Brosseau S; Hanoux V; Creveuil C; Danel C; Bergot E; Scherpereel A; Mazières J; Margery J; Greillier L; Audigier-Valette C; Moro-Sibilot D; Molinier O; Corre R; Monnet I; Gounant V; Langlais A; Morin F; Levallet G; Zalcman G
Br J Cancer; 2019 Feb; 120(4):387-397. PubMed ID: 30739911
[TBL] [Abstract][Full Text] [Related]
18. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
Andersen M; Trapani D; Ravn J; Sørensen JB; Andersen CB; Grauslund M; Santoni-Rugiu E
Anticancer Res; 2015 Nov; 35(11):6223-9. PubMed ID: 26504055
[TBL] [Abstract][Full Text] [Related]
19. A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.
Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Sato A; Tsujimura T; Ueda H; Makihata S; Kato F; Iwasaki A; Nabeshima K
Lung Cancer; 2018 Nov; 125():198-204. PubMed ID: 30429020
[TBL] [Abstract][Full Text] [Related]
20. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
